Triggering of TNFRSF25 promotes CD8⁺ T-cell responses and anti-tumor immunity (Q34630412)

3 August 2017

title

Triggering of TNFRSF25 promotes CD8⁺ T-cell responses and anti-tumor immunity (English)

1 reference

3 August 2017

Tomasz J Slebioda

1

1 reference

3 August 2017

Tania F Rowley

2

1 reference

3 August 2017

John R Ferdinand

3

1 reference

3 August 2017

Jane E Willoughby

4

1 reference

3 August 2017

Sarah L Buchan

5

1 reference

3 August 2017

Vadim Y Taraban

6

1 reference

3 August 2017

Aymen Al-Shamkhani

7

1 reference

3 August 2017

language of work or name

English

0 references

publication date

4 August 2011

1 reference

European Journal of Immunology

3 August 2017

published in

1 reference

3 August 2017

volume

41

1 reference

3 August 2017

issue

9

1 reference

3 August 2017

page(s)

2606-2611

1 reference

The TNF and TNF receptor superfamilies: integrating mammalian biology

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141477

7 January 2021

A death-domain-containing receptor that mediates apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141477

7 January 2021

Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141477

7 January 2021

TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141477

7 January 2021

Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141477

7 January 2021

The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141477

7 January 2021

Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141477

7 January 2021

TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141477

7 January 2021

Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141477

7 January 2021

Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141477

7 January 2021

TL1A selectively enhances IL-12/IL-18-induced NK cell cytotoxicity against NK-resistant tumor targets

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141477

7 January 2021

Dendritic cell quiescence during systemic inflammation driven by LPS stimulation of radioresistant cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141477

7 January 2021

Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141477

7 January 2021

CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141477

7 January 2021

Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141477

7 January 2021

The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141477

7 January 2021

Affinity and kinetics of the interaction between soluble trimeric OX40 ligand, a member of the tumor necrosis factor superfamily, and its receptor OX40 on activated T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141477

7 January 2021

Identifiers

DOI

10.1002/EJI.201141477

1 reference

3 August 2017

1 reference